CD38 and Miyoshi myopathy: It has broad-spectrum killing activity, targeting the transmembrane extracellular enzyme CD38 molecule that highly expressed on the surface of MM cells, which can induce rapid apoptosis of tumor cells through a variety of mechanisms, prolong the survival of patients, and has no serious inhibition of myeloid cell growth [19].